5‐HT1Areceptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

Guide to receptors and channels (GRAC), 5th edition

Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947 · see citing works

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works

Current advances and trends in the treatment of depression

Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113 · see citing works

Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on

Carobrez, A. P., & Bertoglio, L. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.017 · Cited by 993 · see citing works

Role of 5-HT in stress, anxiety, and depression

Graeff, F. G., Guimarães, F. S., De Andrade, T. G. C. S., & Deakin, J. F. W. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02135-3 · Cited by 984 · see citing works

The neurobiology and control of anxious states

Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 963 · see citing works

Stressor specificity of central neuroendocrine responses: implications for stress-related disorders

Pacák, K., & Palkovits, M. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0436 · Cited by 926 · see citing works

Agonistic properties of cannabidiol at 5-HT1a receptors

Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878 · see citing works

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action

Marzo, V. D., Melck, D. J., Bisogno, T., & PETROCELLIS, L. D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 704 · see citing works

Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects

Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608 · see citing works

Pharmacological Actions of Cannabinoids

Pertwee, R. G. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_1 · Cited by 600 · see citing works

Is there a role for 5-HT1A agonists in the treatment of depression?

Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529 · see citing works

Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats

Vergé, D., Daval, G., Marcinkiewicz, M. M., Patey, A., Mestikawy, S. E., GOZLAN, H., & Hamon, M. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-12-03474.1986 · Cited by 518 · see citing works

Cannabidiol: An Overview of Some Pharmacological Aspects

Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 511 · see citing works

Guide to Receptors and Channels (GRAC), 3rd edition

Alexander, S. P. H., Mathie, A. A., & Peters, J. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707746 · Cited by 510 · see citing works

Marihuana Chemistry

Mechoulam, R. (1970) · Science · doi:10.1126/science.168.3936.1159 · Cited by 494 · see citing works

Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716

Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 479 · see citing works

Psychiatric effects of cannabis

Johns, A. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 472 · see citing works

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

Martin, B. R., Compton, D. M., Thomas, B. F., Prescott, W. R., Little, P., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R., & Ward Susan, J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90349-7 · Cited by 410 · see citing works

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 402 · see citing works

Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic study

Chalmers, D. T., & Watson, S. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90748-k · Cited by 388 · see citing works

Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype

Vergé, D., Daval, G., Patey, A., GOZLAN, H., Mestikawy, S. E., & Hamon, M. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90099-8 · Cited by 385 · see citing works

Antianxiety effect of cannabidiol in the elevated plus-maze

Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379 · see citing works

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364 · see citing works

Chemical Basis of Hashish Activity

Mechoulam, R., Shani, A., Edery, H., & Grunfeld, Y. (1970) · Science · doi:10.1126/science.169.3945.611 · Cited by 331 · see citing works

Pharmacological characterization of cannabinoids in the elevated plus maze.

Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312 · see citing works

Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats

Lichtman, A. H., Dimen, K. R., & Martin, B. R. (1995) · Psychopharmacology · doi:10.1007/bf02246292 · Cited by 311 · see citing works

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

Karniol, I. G., Shirakawa, I., Kasinski, N., Pfeferman, A., & Carlini, E. A. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90129-0 · Cited by 303 · see citing works

A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze

Korte, S. M., & de Boer, S. F. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01279-2 · Cited by 293 · see citing works

Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors

Zhuang, X. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00047-0 · Cited by 276 · see citing works

Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats

Kennett, G. A., Dickinson, S. L., & Curzon, G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90684-5 · Cited by 254 · see citing works

Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects

Mechoulam, R., & Hanuš, L. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00144-5 · Cited by 250 · see citing works

Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists

Thomas, B. F., Gilliam, A. F., Burch, D. F., Roche, M. J., & Seltzman, H. H. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37365-3 · Cited by 242 · see citing works

Comparative Study of Pre- and Postsynaptic 5-HT1AReceptor Modulation of Anxiety in Two Ethological Animal Tests

File, S. E., Gonzalez, L. E., & Andrews, N. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04810.1996 · Cited by 230 · see citing works

Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression

Kennett, G. A., Dourish, C. T., & Curzon, G. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90357-8 · Cited by 229 · see citing works

Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine 1A Receptor–Dependent Mechanism

Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., & Fujiwara, M. (2005) · Stroke · doi:10.1161/01.str.0000163083.59201.34 · Cited by 225 · see citing works

Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.

Compton, D. M., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11216-0 · Cited by 216 · see citing works

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207 · see citing works

Effects of cannabidiol in animal models predictive of antipsychotic activity

Zuardi, A. W., Antunes Rodrigues, J., & Cunha, J. M. (1991) · Psychopharmacology · doi:10.1007/bf02244189 · Cited by 191 · see citing works

Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats

Resstel, L. B. M., Joca, S. R. L., Moreira, F. A., Corrêa, F. M. A., & Guimarães, F. S. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.016 · Cited by 182 · see citing works

Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors

Petitet, F., Jeantaud, B., Reibaud, M., Impérato, A., & Dubroeucq, M. C. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00238-0 · Cited by 180 · see citing works

Central serotonergic responses and behavioural adaptation to repeated immobilisation: The effect of the corticosterone synthesis inhibitor metyrapone

Kennett, G. A., Dickinson, S. L., & Curzon, G. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90290-0 · Cited by 175 · see citing works

Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive Rats

Kim‐Mitsuyama, S., Yamamoto, E., Tanaka, T., Zhan, Y., Izumi, Y., Izumiya, Y., Ioroi, T., Wanibuchi, H., & Iwao, H. (2005) · Stroke · doi:10.1161/01.str.0000163084.16505.e3 · Cited by 173 · see citing works

Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids

Ilan, A. B., Gevins, A., Coleman, M., Elsohly, M., & de Wit, H. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00023 · Cited by 169 · see citing works

(−)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens

Pertwee, R. G., Ross, R. A., Craib, S. J., & Thomas, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02624-9 · Cited by 156 · see citing works

Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus

Tsetsenis, T., Ma, X.-H., Iacono, L. L., Beck, S. G., & Gross, C. T. (2007) · Nature Neuroscience · doi:10.1038/nn1919 · Cited by 147 · see citing works

Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems

Joca, S. R. L., Ferreira, F. R., & Guimarães, F. S. (2007) · Stress · doi:10.1080/10253890701223130 · Cited by 137 · see citing works

Restraint-induced hypoactivity in an elevated plus-maze

Padovan, C. M., & Guimarães, F. S. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000000100011 · Cited by 133 · see citing works

An Assessment of Anxiolytic Drug Screening Tests: Hormetic Dose Responses Predominate

Calabrese, E. J. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802014238 · Cited by 132 · see citing works

Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.

Fadda, P., Robinson, L., Fratta, W., Pertwee, R., & Riedel, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.009 · Cited by 122 · see citing works

Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin1A receptors

Kusserow, H., Davies, B., Hörtnagl, H., Voigt, I., Stroh, T., Bert, B., Deng, D. R., Fink, H., Veh, R. W., & Theuring, F. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.06.028 · Cited by 120 · see citing works

Hippocampal 5-HT receptors and consolidation of stressful memories

Guimarães, F. S., Bel, E. A. D., Padovan, C. M., Netto, S. M., & Titze‐de‐Almeida, R. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90098-b · Cited by 112 · see citing works

Activation of post-synaptic 5-HT1A receptors in the dorsal hippocampus prevents learned helplessness development

Joca, S. R. L., Padovan, C. M., & Guimarães, F. S. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02943-3 · Cited by 108 · see citing works

Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze

Zangrossi, H., Viana, M. D. B., Zanoveli, J. M., Bueno, C. H., Nogueira, R. L., & Graeff, F. G. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00047-1 · Cited by 103 · see citing works

L-NAME prevents anxiety-like and depression-like behaviour in rats exposed to restraint stress

Sevgi, S., Özek, M., & Eroǧlu, L. (2006) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2006.28.2.977840 · Cited by 93 · see citing works

Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism

Hayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Irie, K., Fujioka, M., Orito, K., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04565.x · Cited by 84 · see citing works

Role of the medial prefrontal cortex in cardiovascular responses to acute restraint in rats

Tavares, R. F., & Corrêa, F. M. D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.030 · Cited by 83 · see citing works

Metabolism of anandamide and 2‐arachidonoylglycerol: An historical overview and some recent developments

Marzo, V. D., PETROCELLIS, L. D., Bisogno, T., & Melck, D. J. (1999) · Lipids · doi:10.1007/bf02562332 · Cited by 81 · see citing works

Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors

Zhuang, X., Gross, C. T., Santarelli, L., Compan, V., Trillat, A., & Hen, R. (1999) · Neuropsychopharmacology · doi:10.1038/sj.npp.1395371 · Cited by 81 · see citing works

Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test

Kaster, M. P., Santos, A. R. S., & Rodrigues, A. L. S. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.05.025 · Cited by 75 · see citing works

Different effects of 5-HT 1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test

Tsuji, M., Takeda, H., & Matsumiya, T. (2000) · Psychopharmacology · doi:10.1007/s002130000514 · Cited by 65 · see citing works

The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats

Dekeyne, A., Brocco, M., Adhumeau-Auclair, A., Gobert, A., & Millan, M. J. (2000) · Psychopharmacology · doi:10.1007/s002130000449 · Cited by 62 · see citing works

5‐Hydroxytryptamine1AReceptor Agonists in Animal Models of Depression and Anxiety

Kostowski, W., Dyr, W., Krząścik, P., Järbe, T. U. C., & Archer, T. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb00515.x · Cited by 55 · see citing works

Distribution and characterization of anandamide amidohydrolase in mouse brain and liver

Watanabe, K., Ogi, H., Nakamura, S., Kayano, Y., Matsunaga, T., Yoshimura, H., & Yamamoto, I. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00052-6 · Cited by 53 · see citing works

Acute effects of nicotine on restraint stress-induced anxiety-like behavior, c-Fos expression, and corticosterone release in mice

Hsu, H., Chen, T.-Y., Chan, M., & Chen, H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.040 · Cited by 51 · see citing works

Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor

Kagamiishi, Y., Yamamoto, T., & Watanabe, S. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.021 · Cited by 47 · see citing works

Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts

Fadda, P., Robinson, L., Fratta, W., et al. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.11.022 · Cited by 37 · see citing works

Pre- or postsynaptic activity of 5-HT1A compounds in mice depends on the anxiety paradigm

López‐Rubalcava, C. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(96)00018-4 · Cited by 28 · see citing works

Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats

McQueen, D. S., Bond, S. M., Smith, P., Balali-Mood, K., & Smart, D. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.03.045 · Cited by 26 · see citing works

5‐HT1A Receptor Activation before Acute Stress Counteracted the Induced Long‐Term Behavioral Effects

Rioja, J., Santín, L. J., Garcia‐Fernandez, M. I., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.041 · Cited by 10 · see citing works

Serotonin-1A receptor responsiveness in stress and following adaptation to stress.

Samad, N., & Haleem, D. J. (2007) · PubMed · Cited by 5 · see citing works

Safety and side effects of cannabidiol, a Cannabis sativa constituent

Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558 · see citing works

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report

Crippa, J. A. S., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., Simões, M. V., Bhattacharyya, S., Fusar-Poli, P., Atakan, Z., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379283 · Cited by 535 · see citing works

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · see citing works

Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT_1Areceptors

Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366 · see citing works

Cannabis and adolescent brain development.

Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360 · see citing works

Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes

Jin, D., Dai, K., Xie, Z., & Chen, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-60172-6 · Cited by 348 · see citing works

Phytocannabinoids as novel therapeutic agents in {CNS} disorders.

Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312 · see citing works

Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age

Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · see citing works

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306 · see citing works

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors

Bakas, T., van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C., & Chebib, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.022 · Cited by 246 · see citing works

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222 · see citing works

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175 · see citing works

On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment

Stern, C. A. J., Gazarini, L., Takahashi, R. N., Guimarães, F. S., & Bertoglio, L. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.63 · Cited by 156 · see citing works

Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors

Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.033 · Cited by 156 · see citing works

Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats

Lemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.045 · Cited by 146 · see citing works

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors

Casarotto, P. C., Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833b33c5 · Cited by 141 · see citing works

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors

Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139 · see citing works

Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice

Schiavon, A. P., Bonato, J. M., Milani, H., Guimarães, F. S., & Weffort de Oliveira, R. M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.017 · Cited by 135 · see citing works

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

Soares, V. D. P., Campos, A. C., Bortoli, V. C. D., Zangrossi, H., Guimarães, F. S., & Zuardi, A. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.004 · Cited by 112 · see citing works

Prohedonic effect of cannabidiol in a rat model of depression

Shoval, G., Shbiro, L., Hershkovitz, L., Hazut, N., Zalsman, G., Mechoulam, R., & Weller, A. (2016) · Neuropsychobiology · doi:10.1159/000443890 · Cited by 110 · see citing works

Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT _1A receptors

Gomes, F. V., Reis, D. G., Alves, F. H., Corrêa, F. M., Guimarães, F. S., & Resstel, L. B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881110389095 · Cited by 97 · see citing works

A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol

Sultan, S. R., Millar, S. A., England, T. J., & O'Sullivan, S. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00081 · Cited by 95 · see citing works

Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ⁹tetrahydrocannabinol

Wright, M. J., Vandewater, S. A., & Taffe, M. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12199 · Cited by 72 · see citing works

Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor

Gomes, F. V., Alves, F. H. F., Guimarães, F. S., Correa, F. M. A., Resstel, L. B. M., & Crestani, C. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.007 · Cited by 27 · see citing works

The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

Ahmed, M., Boileau, I., Le Foll, B., Carvalho, A. F., & Kloiber, S. (2022) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-1926 · Cited by 11 · see citing works

Elevated plus maze protocol v1Preprint

Venkataraman, A., & Ingraham, H. A. (2022) · doi:10.17504/protocols.io.dm6gpj8kdgzp/v1 · Cited by 2 · see citing works

Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze

Rogério, R., & Takahashi, R. N. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90203-r · Cited by 107 · see citing works

Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze

Anseloni, V. Z., & o, M. L. B. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00011 · Cited by 119 · see citing works

Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice.

Volke, V., Wegener, G., & Vasar, E. (2003) · PubMed · Cited by 67 · see citing works

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat

Pellow, S., & File, S. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90552-6 · Cited by 1,534 · see citing works